Though the big game has long been hallowed ground for some of the most entertaining and memorable commercials, they often don ...

Novartis AG (NVS) stock saw a modest uptick, ending the day at $105.48 which represents a slight increase of $0.76 or 0.73% from the prior close of $104.72. The stock opened at $104.47 and touched a ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Additionally, as the Sandoz spin-off was completed on October 2023, there were no operating results in 2024 related to discontinued operations.

Fox sold out of its inventory of in-game spots by early November, with a 30-second commercial reportedly going for $7 million ...

CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if ...

The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

Deutsche Bank upgraded Novartis (NVS) to Buy from Hold with a price target of CHF 110, up from CHF 100. The firm says the company’s ...

In this article, we review a number of notable Canadian trademark cases from 2024 and highlight key developments in Canadian ...

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune ...

Such companies can be wonderful options for income-seeking investments. If you're in the market for that combo, let's ...

Novartis has become the latest drugmaker to get in trouble over an employee’s LinkedIn likes. The U.K. | Novartis has become ...